Abstract
The 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB) is responsible for maintaining the cellular levels of fructose-2,6-bisphosphate which is a key regulator of glycolysis. Here we have studied the expression of PFKFB-4 isozyme in the DB-1 melanoma cells. An additional isoform of PFKFB-4 mRNA with 148 bases insert in the amino-terminal region at high constitutive levels was identified in these cells. The expression of this splice isoform as well as main isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase was responsible to hypoxia and dimethyloxalylglycine, an inhibitor of HIF-1 α hydroxylase enzymes, suggesting that the hypoxia responsiveness of PFKFB-4 gene in these cells is regulated by HIF-1α protein. Hypoxic induction of PFKFB4 mRNA in the DB-1 melanoma cells correlates with the expression of PFKFB-3 and VEGF mRNA which are known as HIF-1 dependent genes. Thus, our results clearly demonstrated the existence of splice isoform of PFKFB-4 mRNA in the DB-1 melanoma cells and its overexpression under hypoxic conditions. (Mol Cell Biochem xxx: 277–234, 2005)
References
Pilkis SJ, Claus TH, Kurland IJ, Lange AJ: 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme. Annu Rev Biochem 64: 799–835, 1995
Okar DA, Lange AJ: Fructose-2,6-bisphosphate and control of carbohydrate metabolism in eukaryotes. Biofactors 10: 1–14, 1999
Rider MH, Bertrand L, Vertommen D, Michels PA, Rousseau GG, Hue L: 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-head with a bifunctional enzyme that controls glycolysis. Biochem J 381: 561–579, 2004
Rousseau GG, Hue L: Mammalian 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a bifunctional enzyme that control glycolysis. Prog Nucleic Acid Res Mol Biol 45: 99–127, 1993
Okar DA, Manzano A, Navarro-Sabate A, Riera L, Bartrons R, Lange A: PFK-2/FBPase-2: Maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci 26: 30–35, 2001
Sakata J, Abe Y, Uyeda K: Molecular cloning of the DNA and expression and characterization of rat testes fructose-6-phosphate,2-kinase: fructose-2,6-bisphosphatase. J Biol Chem 266: 15764–15770, 1991
Manzano A, Perez JX, Nadal M, Estivill X, Lange A, Bartrons R: Cloning, expression and chromosomal localization of a human testis 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. Gene 229: 83–89, 1999
Sakakibara R, Okudaira T, Fujiwara K, Kato M, Hirata T, Yamanaka S, Naito M, Fukasawa M: Tissue distribution of placenta-type 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Biochem Biophys Res Commun 257: 177–181, 1999
Minchenko O, Opentanova I, Caro J: Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 gene family (PFKFB-1-4) expression in vivo. FEBS Lett 554: 264–270, 2003
Gleade JM, Ratcliffe PJ: Hypoxia and the regulation of gene expression. Mol Med Today 4: 122–129, 1998
Ratcliffe PJ, O'Rourke JF, Maxwell PH, Pugh CW: Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 201: 1153–1162, 1998
Semenza GL: O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J Appl Physiol 96: 1173–1177, 2004
Semenza GL: Hypoxia-inducible factor-1 and the molecular physiology of oxygen homeostasis. J Lab Clin Med 131: 207–214, 1998
Metzen E, Ratcliffe PJ: HIF hydroxylation and cellular oxygen sensing. Biol Chem 385: 223–230, 2004
Ratcliffe PJ: From erythropoietin to oxygen: hypoxia-inducible factor hydroxylases and the hypoxia signal pathway. Blood Purif 20: 445–450, 2002
Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ: Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumor suppressor by mRNA differential expression profiling. Oncogene 19: 6297–6305, 2000
Wykoff CC, Pugh CW, Harris AL, Maxwell PH, Ratcliffe PJ: The HIF pathway: implications for patterns of gene expression in cancer. Novartis Found Symp 240: 212–225, 2001
Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, Johnson RS: Hypoxia-inducible factor-1 is a positive factor in solid tumor growth. Cancer Res 60: 4010–4015, 2000
Minchenko A, Caro J: Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol Cell Biochem 208: 53–62, 2000
Schofield CJ, Ratcliffe PJ: Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343–354, 2004
Minchenko AG, Leshchinsky I, Opentanova I, Sang N, Srinivas V, Armstead VE, Caro J: Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 277: 6183–6187, 2002
Minchenko OH, Opentanova IL, Minchenko DO, Ogura T, Esumi H: Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 gene via hypoxia-inducible factor-1α activation. FEBS Lett 554: 14–20, 2004
Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, Hue L: Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischemia. Curr Biol 19: 1247–1255, 2000
Hue L, Beauloye C, Marsin AS, Bertrand L, Horman S, Rider MH: Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways. J Mol Cell Cardiol 34: 1091–1097, 2002
Marsin AS, Douzin C, Bertrand L, Hue L: The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase. J Biol Chem 277: 30778–30783, 2002
Hue L, Beauloye C, Bertrand L, Horman S, Krause U, Marsin A-S, Meisse D, Vertommen D, Rider MH: New targets of AMP-activated protein kinase. Biochem Soc Trans 31: 213–215, 2003
Minchenko A, Bauer T, Salceda S, Caro J: Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71: 374–379, 1994
Armstead VE, Minchenko AG, Campbell B, Lefer AM: P-selectin is up-regulated in vital organs during murine traumatic shock. FASEB J 11: 1271–1279, 1997
Van Schaftingen E, Lederer B, Bartrons R, Hers H-G: A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose-2,6-bisphosphate. Eur J Biochem 129: 191–195, 1982
Minchenko OH, Opentanova IL, Minchenko DO, Kurashima Y, Esumi H: Homo sapiens 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) mRNA, complete cds, alternatively spliced. GenBank Accession Number AY 714243, 2004
Wenger RH: Cellular adaptation to hypoxia: O2-Sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 16: 1151–1162, 2002
Atsumi T, Chesney J, Metz C, Leng L, Donnelly S, Makita Z, Mitchell R, Bucala R: High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (iPFK-2; PFKFB3) in human cancers. Cancer Res 62: 5881–5887, 2002
Chesney J, Mitchell R, Benigni F, Bacher M, Spiegel L, Al-Abed Y, Han JH, Metz C, Bucala R: An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci USA 96: 3047–3052, 1999
Nissler K, Petermann H, Wenz I, Brox D: Fructose-2,6-bisphosphate metabolism in Erlich ascites tumor cells. J Cancer Res Clin Oncol 121: 739–745, 1995
Tominaga N, Minami Y, Sakakibara R, Uyeda K: Significance of the aminoterminus of rat testis fructose-6-phosphate,2-kinase:fructose-2,6-bisphosphatase. J Biol Chem 268: 15951–15957, 1993
Warburg O: On respiratory impairment in cancer cells. Science 123: 309–314, 1956
Hopfl G, Ogunshola O, Gassmann M: HIFs and tumors – causes and consequences. Am J Physiol 286: R608–R623, 2004
Lu H, Forbes RA, Verma A: Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277: 23111–23115, 2002
Kawaguchi T, Veech RL, Uyeda K: Regulation of energy metabolism in macrophages during hypoxia. Roles of fructose 2,6-bisphosphate and ribose 1,5-bisphosphate. J Biol Chem 276: 28554–28561, 2001
Watanabe F, Furuya E: Tissue-specific alternative splicing of rat brain fructose 6-phosphate 2-kinase/fructose 2,6-bisphosphatase. FEBS Lett 458: 304–308, 1999
Watanabe F, Furuya E: Alternative splicing of novel exons of rat heart-type fructose-6-phosphate 2-kinase/fructose-2,6-bisphosphatase gene. Biochem Biophys Res Commun 282: 803–810, 2001
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Minchenko, O.H., Ogura, T., Opentanova, I.L. et al. Splice isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4: Expression and hypoxic regulation. Mol Cell Biochem 280, 227–234 (2005). https://doi.org/10.1007/s11010-005-8009-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-8009-6